Let us begin.
I want to welcome everybody here.
We have Mr. David Lee, director of the office of legislative and regulatory modernization at the policy, planning and international affairs directorate, health products and food branch. Wow! Is that ever a long title, Mr. Lee—well deserved.
Also we have by teleconference, from the Canadian Organization for Rare Disorders, Dr. Wong-Rieger, president and chief executive officer. She is joining us from Geneva.
We're very honoured to have you here.
I'm going to begin with Dr. Wong-Rieger.
Doctor, you have 10 minutes for your presentation. Then Mr. Lee will take over from you. Do you understand that, Dr. Wong-Rieger?